A STUDY assessing coronary proximity in patients undergoing transcatheter pulmonary valve replacement (TPVR) with ...

Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

Janet Furr didn't experience typical heart attack symptoms when she had a 'widowmaker' heart attack in July 2024.

FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...

Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, today announced it has ...

This is the most common type of heart disease in the U.S., according to the CDC. Also known as coronary artery disease, this ...

The film presents a detailed fluorographic study of the normal heart using venous catheterization, showcasing physiological data such as pressure and flow measurements. It illustrates blood flow ...

A national leader in the cardiovascular field has reaccredited UPMC Somerset’s Percutaneous Coronary Intervention program.

Ph.D., professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, and one of the researchers on the study. The study enrolled more than 23,000 adults from ...

Chin Med J 2011; 124: 4172-7. 6. Buccheri D, Chirco PR, Geraci S, et al. Coronary artery fistulae: anatomy, diagnosis and management strategies. Heart Lung Circ 2018; 27: 940-51. 7. Ateş AH, Kivrak A, ...

Commentary: Induction antiangiogenesis for stage IIIA-N2 non-small cell lung cancer is not the answer yet: Optimal induction for operable disease is a clear work in progress.